Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics
Authors
Keywords
-
Journal
JOURNAL OF BIOTECHNOLOGY
Volume 377, Issue -, Pages 13-22
Publisher
Elsevier BV
Online
2023-10-10
DOI
10.1016/j.jbiotec.2023.10.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PD-L1/4-1BB bispecific Antibody-Anticalin fusion protein PRS-344/S095012 elicits strong T-cell stimulation in a tumor-localized manner
- (2022) Janet K. Peper-Gabriel et al. CLINICAL CANCER RESEARCH
- “HIGH‐RISK” HOST CELL PROTEINS (HCPs): A MULTI‐COMPANY COLLABORATIVE VIEW
- (2021) Marisa Jones et al. BIOTECHNOLOGY AND BIOENGINEERING
- Quantitative N-Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis
- (2021) Bastiaan L. Duivelshof et al. Pharmaceutics
- A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies
- (2020) Gaili Guo et al. PROTEIN EXPRESSION AND PURIFICATION
- Tumor-localized costimulatory T cell engagement by the 4-1BB/HER2 bispecific antibody-Anticalin fusion PRS-343
- (2019) Marlon J Hinner et al. CLINICAL CANCER RESEARCH
- Anticalin® Proteins as Therapeutic Agents in Human Diseases
- (2018) Christine Rothe et al. BIODRUGS
- Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
- (2018) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process
- (2018) Cassia Andrade et al. BIOTECHNOLOGY PROGRESS
- Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab
- (2018) Yan Li et al. Cell Reports
- Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibody
- (2017) Yin Luo et al. mAbs
- 4-1BB–Enhanced Expansion of CD8 + TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8 + T Cells
- (2017) Michiko Harao et al. Cancer Immunology Research
- Cell culture media impact on drug product solution stability
- (2016) Jennifer L. Purdie et al. BIOTECHNOLOGY PROGRESS
- Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity
- (2016) Andrew D. Tustian et al. mAbs
- The Menagerie of Human Lipocalins: A Natural Protein Scaffold for Molecular Recognition of Physiological Compounds
- (2015) André Schiefner et al. ACCOUNTS OF CHEMICAL RESEARCH
- Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
- (2012) Christian Klein et al. mAbs
- Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains
- (2011) Jürgen Schanzer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process
- (2011) Jun Luo et al. BIOTECHNOLOGY AND BIOENGINEERING
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
- (2010) Kannan Gunasekaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
- (2010) Jennifer S. Michaelson et al. mAbs
- Cell culture processes for monoclonal antibody production
- (2010) Feng Li et al. mAbs
- Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
- (2010) Paolo A. Ascierto et al. SEMINARS IN ONCOLOGY
- Recent advances in large-scale production of monoclonal antibodies and related proteins
- (2010) Abhinav A. Shukla et al. TRENDS IN BIOTECHNOLOGY
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Comparison of the ability of wild type and stabilized human IgG4 to undergo Fab arm exchange with endogenous IgG4 in vitro and in vivo
- (2009) Kenneth B. Lewis et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started